calrecia
fresenius medical care deutschland gmbh, nemecko - chlorid vápenatý - 39 - soli a ionty pro p.o. a parent. aplikÁciu
penthrox
medical developments ned b.v., holandsko - metoxyflurán - 65 - analgetica - anodyna
paricalcitol fresenius 5 µg/ml
fresenius medical care nephrologica deutschland gmbh, nemecko - parikalcitol - 87 - varia i
paricalcitol fresenius 2 µg/ml
fresenius medical care nephrologica deutschland gmbh, nemecko - parikalcitol - 87 - varia i
oxacilin avmc 1 000 mg
av medical cz s.r.o., Česká republika - oxacilín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - klopidogrel hydrochlorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotické činidlá - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
datscan
ge healthcare b.v. - ioflupán (123 i) - tomography, emission-computed, single-photon; lewy body disease; parkinson disease; alzheimer disease - diagnostické rádiofarmaká - tento liek je určený len na diagnostické účely. datscan je určený pre detekciu straty funkčné dopaminergic neurón terminálov v striatum:u dospelých pacientov s klinicky neistý parkinsonian syndrómov, napríklad tých s včasné príznaky, s cieľom pomôcť rozlíšiť základné chvenie z parkinsonian syndrómy spojené s idiopatickej parkinsonovej choroby, viaceré systémové atrofie a progresívne supranuclear obrnou. datscan nie je schopný rozlišovať medzi parkinsonova choroba, viaceré systémové atrofie a progresívne supranuclear obrnou. u dospelých pacientov, pomôcť odlíšiť pravdepodobné, demencie s lewy orgánov od alzheimerovej choroby. datscan nie je schopný rozlišovať medzi demenciou s lewy orgánov a parkinsonova choroba, demencia.
minibodec minispike s antibakteriálnym vzduchovým filtrom
multimedical s.r.l. via g. rossa 69, 71, 73 46019 viadana (mn) taliansko -
súprava a byreta na gravitačnú infúziu
multimedical s.r.l. via g. rossa 69, 71, 73 46019 viadana (mn) taliansko -
vak na parenterálnu výživu
multimedical s.r.l. via g. rossa 69, 71, 73 46019 viadana (mn) taliansko -